IP Library Granted Patent US 7,078,547
Granted Patent B2
US 7,078,547 · App. 10/358,990 · Granted Jul 18, 2006

Catalytic asymmetric cyanosilylation of ketones, aldehydes, thioketones, thioaldehydes, imines and hydrazones

Assignee: Brandeis University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,078,547
App. No.
10/358,990
Granted
Jul 18, 2006
Kind
B2
Abstract

One aspect of the present invention relates to a method for the catalytic asymmetric cyanosilylation of ketones, aldehydes, thioketones, thioaldehydes, imines and hydrazones. The critical elements of the method are: a non-racemic chiral tertiary-amine-containing catalyst; a substrate selected from the group consisting of ketones, aldehydes, thioketones, thioaldehydes, imines and hydrazones; and a silyl cyanide, e.g., trimethylsilyl cyanide. In preferred embodiments, the substrate is a ketone or aldehyde. A preferred embodiment of the present invention relates to practicing the method in a halocarbon solvent, e.g., chloroform. Another preferred embodiment of the present invention relates to practicing the method in an ester solvent, e.g., ethyl acetate. In certain embodiments, the methods of the present invention produce a silyl cyanohydrin with an enantiomeric excess greater than about 80%. In certain embodiments, the methods of the present invention produce a silyl cyanohydrin with an enantiomeric excess greater than about 90%.

Claims (45)

1. A method of cyanosilylation of a substrate, comprising the step of combining a silyl cyanide, a substrate selected from the group consisting of ketones, aldehydes, thioketones, thioaldehydes, imines and hydrazones, and a chiral non-racemic catalyst, wherein said chiral non-racemic catalyst is a tertiary amine, phosphine or arsine, and wherein said chiral non-racemic catalyst catalyzes the addition of said silyl cyanide to said substrate to give a chiral non-racemic silyl cyanohydrin.

2. The method of claim 1 , wherein said substrate is a ketone or aldehyde.

3. The method of claim 1 , wherein said silyl cyanide is a trialkylsilyl cyanide.

4. The method of claim 1 , wherein said silyl cyanide is trimethylsilyl cyanide.

5. The method of claim 1 , wherein said chiral non-racemic catalyst is a tertiary amine.

6. The method of claim 1 , wherein said chiral non-racemic catalyst is a cinchona alkaloid.

7. The method of claim 1 , wherein said chiral non-racemic catalyst is quinidine, (DHQ) 2 PHAL, (DHQD) 2 PHAL, (DHQ) 2 PYR, (DHQD) 2 PYR, (DHQ) 2 AQN, (DHQD) 2 AQN, DHQ-CLB, DHQD-CLB, DHQ-MEQ, DHQD-MEQ, DHQ-AQN, DHQD-AQN, DHQ-PHN, or DHQD-PHN.

8. The method of claim 1 , wherein said substrate is a ketone or aldehyde; and said silyl cyanide is a trialkylsilyl cyanide.

9. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is a trialkylsilyl cyanide; and said chiral non-racemic catalyst is a tertiary amine, phosphine or arsine.

10. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is a trialkylsilyl cyanide; and said chiral non-racemic catalyst is a tertiary amine.

11. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is a trialkylsilyl cyanide; and said chiral non-racemic catalyst is a cinchona alkaloid.

12. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is a trialkylsilyl cyanide; and said chiral non-racemic catalyst is quinidine, (DHQ) 2 PHAL, (DHQD) 2 PHAL, (DHQ) 2 PYR, (DHQD) 2 PYR, (DHQ) 2 AQN, (DHQD) 2 AQN, DHQ-CLB, DHQD-CLB, DHQ-MEQ, DHQD-MEQ, DHQ-AQN, DHQD-AQN, DHQ-PHN, or DHQD-PHN.

13. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is trimethylsilyl cyanide; and said chiral non-racemic catalyst is a tertiary amine, phosphine or arsine.

14. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is trimethylsilyl cyanide; and said chiral non-racemic catalyst is a tertiary amine.

15. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is trimethylsilyl cyanide; and said chiral non-racemic catalyst is a cinchona alkaloid.

16. The method of claim 1 , wherein said substrate is a ketone or aldehyde; said silyl cyanide is trimethylsilyl cyanide; and said chiral non-racemic catalyst is quinidine, (DHQ) 2 PHAL, (DHQD) 2 PHAL, (DHQ) 2 PYR, (DHQD) 2 PYR, (DHQ) 2 AQN, (DHQD) 2 AQN, DHQ-CLB, DHQD-CLB, DHQ-MEQ, DHQD-MEQ, DHQ-AQN, DHQD-AQN, DHQ-PHN, or DHQD-PHN.

17. The method of claim 1 , wherein the enantiomeric excess or diastereomeric excess of the chiral non-racemic silyl cyanohydrin is greater than about 50%.

18. The method of claim 1 , wherein the enantiomeric excess or diastereomeric excess of the chiral non-racemic silyl cyanohydrin is greater than about 70%.

19. The method of claim 1 , wherein the enantiomeric excess or diastereomeric excess of the chiral non-racemic silyl cyanohydrin is greater than about 90%.

20. A method of asymmetric cyanosilylation represented by Scheme 1:

wherein

X represents O, S, NR′, or NN(R′)(R″);

R represents independently for each occurrence alkyl, cycloalkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl;

R′ represents independently for each occurrence alkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, aralkyl, or heteroaralkyl;

R″ represents independently for each occurrence H, alkyl, cycloalkyl, alkenyl, alkynyl, aryl, heteroaryl, aralkyl, or heteroaralkyl;

R′ and R″ are not identical;

the product is chiral and non-racemic; and

chiral non-racemic catalyst is a chiral non-racemic tertiary amine, phosphine, or arsine.

21. The method of claim 20 , wherein X represents O.

22. The method of claim 20 , wherein R represents independently for each occurrence alkyl.

23. The method of claim 20 , wherein R represents independently for each occurrence methyl.

24. The method of claim 20 , wherein said chiral non-racemic catalyst is a chiral non-racemic tertiary amine.

25. The method of claim 20 , wherein said chiral non-racemic catalyst is a cinchona alkaloid.

26. The method of claim 20 , wherein said chiral non-racemic catalyst is quinidine, (DHQ) 2 PHAL, (DHQD) 2 PHAL, (DHQ) 2 PYR,(DHQD) 2 PYR, (DHQ) 2 AQN, (DHQD) 2 AQN, DHQ-CLB, DHQD-CLB, DHQ-MEQ, DHQD-MEQ, DHQ-AQN, DHQD-AQN, DHQ-PHN, or DHQD-PHN.

27. The method claim 20 , wherein X represents O; and R represents independently for each occurrence alkyl.

28. The method of claim 20 , wherein X represents O; R represents independently for each occurrence alkyl; and said chiral non-racemic catalyst is a chiral non-racemic tertiary amine.

29. The method of claim 20 , wherein X represents O; R represents independently for each occurrence alkyl; and said chiral non-racemic catalyst is a cinchona alkaloid.

30. The method of claim 20 , wherein X represents O; R represents independently for each occurrence alkyl; and said chiral non-racemic catalyst is quinidine, (DHQ) 2 PHAL, (DHQD) 2 PHAL, (DHQ) 2 PYR, (DHQD) 2 PYR, (DHQ) 2 AQN, (DHQD) 2 AQN, DHQ-CLB, DHQD-CLB, DHQ-MEQ, DHQD-MEQ, DHQ-AQN, DHQD-AQN, DHQ-PHN, or DHQD-PHN.

31. The method of claim 20 , wherein X represents O; and R represents independently for each occurrence methyl.

32. The method of claim 20 , wherein X represents O; R represents independently for each occurrence methyl; and said chiral non-racemic catalyst is a chiral non-racemic tertiary amine.

33. The method of claim 20 , wherein X represents O; R represents independently for each occurrence methyl; and said chiral non-racemic catalyst is a cinchona alkaloid.

34. The method of claim 20 , wherein X represents O; R represents independently for each occurrence methyl; and said chiral non-racemic catalyst is quinidine, (DHQ) 2 PHAL, (DHQD) 2 PHAL, (DHQ) 2 PYR, (DHQD) 2 PYR, (DHQ) 2 AQN, (DHQD) 2 AQN, DHQ-CLB, DHQD-CLB, DHQ-MEQ, DHQD-MEQ, DHQ-AQN, DHQD-AQN, DHQ-PHN, or DHQD-PHN.

35. The method of claim 20 , wherein the enantiomeric excess or diastereomeric excess of the product is greater than about 50%.

36. The method of claim 20 , wherein the enantiomeric excess or diastereomeric excess of the product is greater than about 70%.

37. The method of claim 20 , wherein the enantiomeric excess or diastereomeric excess of the product is greater than about 90%.

Assignments (2)
CORRECTIVE ASSIGNMENT OF INCORRECT SERIAL 10/358,993 PREVIOUSLY RECORDED AT REEL 021987 FRAME 0805. THE ASSIGNOR HEREBY CONFIRMS THE EXECUTIVE ORDER 9424 CONFIRMATORY LICENSE. Recorded Nov 9, 2010
From: BRANDEIS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH) DEPARTMENT OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025997/0403 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2005
From: DENG, LI; TIAN, SHI-KAN
To: BRANDEIS UNIVERSITY
Reel/Frame 016025/0876 →
Continuity (2)
Provisional Application 6035699300 · Feb 13, 2002
Related Publication 20030236226A1 · Dec 25, 2003